Global C-X-C Chemokine Receptor Type 4 Market Research Report 2021

Publisher Name :
Date: 04-Feb-2021
No. of pages: 122
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- AM-3114

- BL-8040

- GMI-1359

- HPH-112

- Others

Segment by Application

- Liver Cancer

- Myocardial Infarction

- Renal Cell Carcinoma

- Stroke

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- AdAlta Pty Ltd.

- Ambrx, Inc.

- Anchor Therapeutics, Inc.

- Biokine Therapeutics Ltd.

- BioLineRx, Ltd.

- Bristol-Myers Squibb Company

- Eli Lilly and Company

- Globavir Biosciences, Inc.

- GlycoMimetics, Inc.

- NeED Pharma s.r.l.

- Pharis Biotec GmbH

- Polyphor Ltd.

- Sanofi

- TaiGen Biotechnology Co., Ltd.

- Upsher-Smith Laboratories, Inc.

- X4 Pharmaceuticals, Inc.

Global C-X-C Chemokine Receptor Type 4 Market Research Report 2021

Table of Contents
1 C-X-C Chemokine Receptor Type 4 Market Overview
1.1 Product Overview and Scope of C-X-C Chemokine Receptor Type 4
1.2 C-X-C Chemokine Receptor Type 4 Segment by Type
1.2.1 Global C-X-C Chemokine Receptor Type 4 Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 AM-3114
1.2.3 BL-8040
1.2.4 GMI-1359
1.2.5 HPH-112
1.2.6 Others
1.3 C-X-C Chemokine Receptor Type 4 Segment by Application
1.3.1 C-X-C Chemokine Receptor Type 4 Sales Comparison by Application: (2021-2027)
1.3.2 Liver Cancer
1.3.3 Myocardial Infarction
1.3.4 Renal Cell Carcinoma
1.3.5 Stroke
1.3.6 Others
1.4 Global C-X-C Chemokine Receptor Type 4 Market Size Estimates and Forecasts
1.4.1 Global C-X-C Chemokine Receptor Type 4 Revenue 2016-2027
1.4.2 Global C-X-C Chemokine Receptor Type 4 Sales 2016-2027
1.4.3 C-X-C Chemokine Receptor Type 4 Market Size by Region: 2016 Versus 2021 Versus 2027
2 C-X-C Chemokine Receptor Type 4 Market Competition by Manufacturers
2.1 Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Manufacturers (2016-2021)
2.2 Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Manufacturers (2016-2021)
2.3 Global C-X-C Chemokine Receptor Type 4 Average Price by Manufacturers (2016-2021)
2.4 Manufacturers C-X-C Chemokine Receptor Type 4 Manufacturing Sites, Area Served, Product Type
2.5 C-X-C Chemokine Receptor Type 4 Market Competitive Situation and Trends
2.5.1 C-X-C Chemokine Receptor Type 4 Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest C-X-C Chemokine Receptor Type 4 Players Market Share by Revenue
2.5.3 Global C-X-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 C-X-C Chemokine Receptor Type 4 Retrospective Market Scenario by Region
3.1 Global C-X-C Chemokine Receptor Type 4 Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global C-X-C Chemokine Receptor Type 4 Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Country
3.3.1 North America C-X-C Chemokine Receptor Type 4 Sales by Country
3.3.2 North America C-X-C Chemokine Receptor Type 4 Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Country
3.4.1 Europe C-X-C Chemokine Receptor Type 4 Sales by Country
3.4.2 Europe C-X-C Chemokine Receptor Type 4 Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Region
3.5.1 Asia Pacific C-X-C Chemokine Receptor Type 4 Sales by Region
3.5.2 Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Country
3.6.1 Latin America C-X-C Chemokine Receptor Type 4 Sales by Country
3.6.2 Latin America C-X-C Chemokine Receptor Type 4 Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Country
3.7.1 Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales by Country
3.7.2 Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global C-X-C Chemokine Receptor Type 4 Historic Market Analysis by Type
4.1 Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2021)
4.2 Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type (2016-2021)
4.3 Global C-X-C Chemokine Receptor Type 4 Price by Type (2016-2021)
5 Global C-X-C Chemokine Receptor Type 4 Historic Market Analysis by Application
5.1 Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2021)
5.2 Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application (2016-2021)
5.3 Global C-X-C Chemokine Receptor Type 4 Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AdAlta Pty Ltd.
6.1.1 AdAlta Pty Ltd. Corporation Information
6.1.2 AdAlta Pty Ltd. Description and Business Overview
6.1.3 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AdAlta Pty Ltd. Product Portfolio
6.1.5 AdAlta Pty Ltd. Recent Developments/Updates
6.2 Ambrx, Inc.
6.2.1 Ambrx, Inc. Corporation Information
6.2.2 Ambrx, Inc. Description and Business Overview
6.2.3 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Ambrx, Inc. Product Portfolio
6.2.5 Ambrx, Inc. Recent Developments/Updates
6.3 Anchor Therapeutics, Inc.
6.3.1 Anchor Therapeutics, Inc. Corporation Information
6.3.2 Anchor Therapeutics, Inc. Description and Business Overview
6.3.3 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Anchor Therapeutics, Inc. Product Portfolio
6.3.5 Anchor Therapeutics, Inc. Recent Developments/Updates
6.4 Biokine Therapeutics Ltd.
6.4.1 Biokine Therapeutics Ltd. Corporation Information
6.4.2 Biokine Therapeutics Ltd. Description and Business Overview
6.4.3 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biokine Therapeutics Ltd. Product Portfolio
6.4.5 Biokine Therapeutics Ltd. Recent Developments/Updates
6.5 BioLineRx, Ltd.
6.5.1 BioLineRx, Ltd. Corporation Information
6.5.2 BioLineRx, Ltd. Description and Business Overview
6.5.3 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.5.4 BioLineRx, Ltd. Product Portfolio
6.5.5 BioLineRx, Ltd. Recent Developments/Updates
6.6 Bristol-Myers Squibb Company
6.6.1 Bristol-Myers Squibb Company Corporation Information
6.6.2 Bristol-Myers Squibb Company Description and Business Overview
6.6.3 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bristol-Myers Squibb Company Product Portfolio
6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.7 Eli Lilly and Company
6.6.1 Eli Lilly and Company Corporation Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eli Lilly and Company Product Portfolio
6.7.5 Eli Lilly and Company Recent Developments/Updates
6.8 Globavir Biosciences, Inc.
6.8.1 Globavir Biosciences, Inc. Corporation Information
6.8.2 Globavir Biosciences, Inc. Description and Business Overview
6.8.3 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Globavir Biosciences, Inc. Product Portfolio
6.8.5 Globavir Biosciences, Inc. Recent Developments/Updates
6.9 GlycoMimetics, Inc.
6.9.1 GlycoMimetics, Inc. Corporation Information
6.9.2 GlycoMimetics, Inc. Description and Business Overview
6.9.3 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.9.4 GlycoMimetics, Inc. Product Portfolio
6.9.5 GlycoMimetics, Inc. Recent Developments/Updates
6.10 NeED Pharma s.r.l.
6.10.1 NeED Pharma s.r.l. Corporation Information
6.10.2 NeED Pharma s.r.l. Description and Business Overview
6.10.3 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.10.4 NeED Pharma s.r.l. Product Portfolio
6.10.5 NeED Pharma s.r.l. Recent Developments/Updates
6.11 Pharis Biotec GmbH
6.11.1 Pharis Biotec GmbH Corporation Information
6.11.2 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Description and Business Overview
6.11.3 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Pharis Biotec GmbH Product Portfolio
6.11.5 Pharis Biotec GmbH Recent Developments/Updates
6.12 Polyphor Ltd.
6.12.1 Polyphor Ltd. Corporation Information
6.12.2 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Description and Business Overview
6.12.3 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Polyphor Ltd. Product Portfolio
6.12.5 Polyphor Ltd. Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi C-X-C Chemokine Receptor Type 4 Description and Business Overview
6.13.3 Sanofi C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sanofi Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 TaiGen Biotechnology Co., Ltd.
6.14.1 TaiGen Biotechnology Co., Ltd. Corporation Information
6.14.2 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Description and Business Overview
6.14.3 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.14.4 TaiGen Biotechnology Co., Ltd. Product Portfolio
6.14.5 TaiGen Biotechnology Co., Ltd. Recent Developments/Updates
6.15 Upsher-Smith Laboratories, Inc.
6.15.1 Upsher-Smith Laboratories, Inc. Corporation Information
6.15.2 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Description and Business Overview
6.15.3 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Upsher-Smith Laboratories, Inc. Product Portfolio
6.15.5 Upsher-Smith Laboratories, Inc. Recent Developments/Updates
6.16 X4 Pharmaceuticals, Inc.
6.16.1 X4 Pharmaceuticals, Inc. Corporation Information
6.16.2 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Description and Business Overview
6.16.3 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.16.4 X4 Pharmaceuticals, Inc. Product Portfolio
6.16.5 X4 Pharmaceuticals, Inc. Recent Developments/Updates
7 C-X-C Chemokine Receptor Type 4 Manufacturing Cost Analysis
7.1 C-X-C Chemokine Receptor Type 4 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of C-X-C Chemokine Receptor Type 4
7.4 C-X-C Chemokine Receptor Type 4 Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 C-X-C Chemokine Receptor Type 4 Distributors List
8.3 C-X-C Chemokine Receptor Type 4 Customers
9 C-X-C Chemokine Receptor Type 4 Market Dynamics
9.1 C-X-C Chemokine Receptor Type 4 Industry Trends
9.2 C-X-C Chemokine Receptor Type 4 Growth Drivers
9.3 C-X-C Chemokine Receptor Type 4 Market Challenges
9.4 C-X-C Chemokine Receptor Type 4 Market Restraints
10 Global Market Forecast
10.1 C-X-C Chemokine Receptor Type 4 Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of C-X-C Chemokine Receptor Type 4 by Type (2022-2027)
10.1.2 Global Forecasted Revenue of C-X-C Chemokine Receptor Type 4 by Type (2022-2027)
10.2 C-X-C Chemokine Receptor Type 4 Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of C-X-C Chemokine Receptor Type 4 by Application (2022-2027)
10.2.2 Global Forecasted Revenue of C-X-C Chemokine Receptor Type 4 by Application (2022-2027)
10.3 C-X-C Chemokine Receptor Type 4 Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of C-X-C Chemokine Receptor Type 4 by Region (2022-2027)
10.3.2 Global Forecasted Revenue of C-X-C Chemokine Receptor Type 4 by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global C-X-C Chemokine Receptor Type 4 Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global C-X-C Chemokine Receptor Type 4 Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global C-X-C Chemokine Receptor Type 4 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers C-X-C Chemokine Receptor Type 4 Covered in This Study
Table 5. Global C-X-C Chemokine Receptor Type 4 Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global C-X-C Chemokine Receptor Type 4 Sales Share by Manufacturers (2016-2021)
Table 7. Global C-X-C Chemokine Receptor Type 4 Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market C-X-C Chemokine Receptor Type 4 Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers C-X-C Chemokine Receptor Type 4 Manufacturing Sites and Area Served
Table 11. Manufacturers C-X-C Chemokine Receptor Type 4 Product Type
Table 12. Global C-X-C Chemokine Receptor Type 4 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global C-X-C Chemokine Receptor Type 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-X-C Chemokine Receptor Type 4 as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global C-X-C Chemokine Receptor Type 4 Sales by Region (2016-2021) & (K Pcs)
Table 16. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Region (2016-2021)
Table 17. Global C-X-C Chemokine Receptor Type 4 Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America C-X-C Chemokine Receptor Type 4 Sales by Country (2016-2021) & (K Pcs)
Table 19. North America C-X-C Chemokine Receptor Type 4 Sales Market Share by Country (2016-2021)
Table 20. North America C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2021)
Table 22. Europe C-X-C Chemokine Receptor Type 4 Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe C-X-C Chemokine Receptor Type 4 Sales Market Share by Country (2016-2021)
Table 24. Europe C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region (2016-2021)
Table 30. Latin America C-X-C Chemokine Receptor Type 4 Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America C-X-C Chemokine Receptor Type 4 Sales Market Share by Country (2016-2021)
Table 32. Latin America C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2021)
Table 38. Global C-X-C Chemokine Receptor Type 4 Sales (K Pcs) by Type (2016-2021)
Table 39. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2021)
Table 40. Global C-X-C Chemokine Receptor Type 4 Revenue (Million US$) by Type (2016-2021)
Table 41. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Type (2016-2021)
Table 42. Global C-X-C Chemokine Receptor Type 4 Price (USD/Pcs) by Type (2016-2021)
Table 43. Global C-X-C Chemokine Receptor Type 4 Sales (K Pcs) by Application (2016-2021)
Table 44. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2021)
Table 45. Global C-X-C Chemokine Receptor Type 4 Revenue (Million US$) by Application (2016-2021)
Table 46. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Application (2016-2021)
Table 47. Global C-X-C Chemokine Receptor Type 4 Price (USD/Pcs) by Application (2016-2021)
Table 48. AdAlta Pty Ltd. Corporation Information
Table 49. AdAlta Pty Ltd. Description and Business Overview
Table 50. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 52. AdAlta Pty Ltd. Recent Developments/Updates
Table 53. Ambrx, Inc. Corporation Information
Table 54. Ambrx, Inc. Description and Business Overview
Table 55. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 57. Ambrx, Inc. Recent Developments/Updates
Table 58. Anchor Therapeutics, Inc. Corporation Information
Table 59. Anchor Therapeutics, Inc. Description and Business Overview
Table 60. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 62. Anchor Therapeutics, Inc. Recent Developments/Updates
Table 63. Biokine Therapeutics Ltd. Corporation Information
Table 64. Biokine Therapeutics Ltd. Description and Business Overview
Table 65. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 67. Biokine Therapeutics Ltd. Recent Developments/Updates
Table 68. BioLineRx, Ltd. Corporation Information
Table 69. BioLineRx, Ltd. Description and Business Overview
Table 70. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 72. BioLineRx, Ltd. Recent Developments/Updates
Table 73. Bristol-Myers Squibb Company Corporation Information
Table 74. Bristol-Myers Squibb Company Description and Business Overview
Table 75. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product
Table 77. Bristol-Myers Squibb Company Recent Developments/Updates
Table 78. Eli Lilly and Company Corporation Information
Table 79. Eli Lilly and Company Description and Business Overview
Table 80. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product
Table 82. Eli Lilly and Company Recent Developments/Updates
Table 83. Globavir Biosciences, Inc. Corporation Information
Table 84. Globavir Biosciences, Inc. Description and Business Overview
Table 85. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 87. Globavir Biosciences, Inc. Recent Developments/Updates
Table 88. GlycoMimetics, Inc. Corporation Information
Table 89. GlycoMimetics, Inc. Description and Business Overview
Table 90. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 92. GlycoMimetics, Inc. Recent Developments/Updates
Table 93. NeED Pharma s.r.l. Corporation Information
Table 94. NeED Pharma s.r.l. Description and Business Overview
Table 95. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product
Table 97. NeED Pharma s.r.l. Recent Developments/Updates
Table 98. Pharis Biotec GmbH Corporation Information
Table 99. Pharis Biotec GmbH Description and Business Overview
Table 100. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Product
Table 102. Pharis Biotec GmbH Recent Developments/Updates
Table 103. Polyphor Ltd. Corporation Information
Table 104. Polyphor Ltd. Description and Business Overview
Table 105. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 107. Polyphor Ltd. Recent Developments/Updates
Table 108. Sanofi Corporation Information
Table 109. Sanofi Description and Business Overview
Table 110. Sanofi C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Sanofi C-X-C Chemokine Receptor Type 4 Product
Table 112. Sanofi Recent Developments/Updates
Table 113. TaiGen Biotechnology Co., Ltd. Corporation Information
Table 114. TaiGen Biotechnology Co., Ltd. Description and Business Overview
Table 115. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Product
Table 117. TaiGen Biotechnology Co., Ltd. Recent Developments/Updates
Table 118. Upsher-Smith Laboratories, Inc. Corporation Information
Table 119. Upsher-Smith Laboratories, Inc. Description and Business Overview
Table 120. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 122. Upsher-Smith Laboratories, Inc. Recent Developments/Updates
Table 123. X4 Pharmaceuticals, Inc. Corporation Information
Table 124. X4 Pharmaceuticals, Inc. Description and Business Overview
Table 125. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Product
Table 127. X4 Pharmaceuticals, Inc. Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. C-X-C Chemokine Receptor Type 4 Distributors List
Table 131. C-X-C Chemokine Receptor Type 4 Customers List
Table 132. C-X-C Chemokine Receptor Type 4 Market Trends
Table 133. C-X-C Chemokine Receptor Type 4 Growth Drivers
Table 134. C-X-C Chemokine Receptor Type 4 Market Restraints
Table 135. Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Type (2022-2027) & (K Pcs)
Table 136. Global C-X-C Chemokine Receptor Type 4 Sales Market Share Forecast by Type (2022-2027)
Table 137. Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Application (2022-2027) & (K Pcs)
Table 140. Global C-X-C Chemokine Receptor Type 4 Sales Market Share Forecast by Application (2022-2027)
Table 141. Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Region (2022-2027) & (K Pcs)
Table 144. Global C-X-C Chemokine Receptor Type 4 Sales Market Share Forecast by Region (2022-2027)
Table 145. Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of C-X-C Chemokine Receptor Type 4
Figure 2. Global C-X-C Chemokine Receptor Type 4 Market Share by Type in 2020 & 2027
Figure 3. AM-3114 Product Picture
Figure 4. BL-8040 Product Picture
Figure 5. GMI-1359 Product Picture
Figure 6. HPH-112 Product Picture
Figure 7. Others Product Picture
Figure 8. Global C-X-C Chemokine Receptor Type 4 Market Share by Application in 2020 & 2027
Figure 9. Liver Cancer
Figure 10. Myocardial Infarction
Figure 11. Renal Cell Carcinoma
Figure 12. Stroke
Figure 13. Others
Figure 14. Global C-X-C Chemokine Receptor Type 4 Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global C-X-C Chemokine Receptor Type 4 Market Size 2016-2027 (US$ Million)
Figure 16. Global C-X-C Chemokine Receptor Type 4 Sales 2016-2027 (K Pcs)
Figure 17. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. C-X-C Chemokine Receptor Type 4 Sales Share by Manufacturers in 2020
Figure 19. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest C-X-C Chemokine Receptor Type 4 Players: Market Share by Revenue in 2020
Figure 21. C-X-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Region (2016-2021)
Figure 23. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Region in 2020
Figure 24. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region (2016-2021)
Figure 25. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region in 2020
Figure 26. U.S. C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of C-X-C Chemokine Receptor Type 4 by Type (2016-2021)
Figure 51. Sales Market Share of C-X-C Chemokine Receptor Type 4 by Application (2016-2021)
Figure 52. Sales Market Share of C-X-C Chemokine Receptor Type 4 by Application in 2020
Figure 53. Revenue Share of C-X-C Chemokine Receptor Type 4 by Application (2016-2021)
Figure 54. Revenue Share of C-X-C Chemokine Receptor Type 4 by Application in 2020
Figure 55. Manufacturing Cost Structure of C-X-C Chemokine Receptor Type 4
Figure 56. Manufacturing Process Analysis of C-X-C Chemokine Receptor Type 4
Figure 57. C-X-C Chemokine Receptor Type 4 Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
  • 2021-2027 Global and Regional Hip and Knee Replacement Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 150
    The global Hip and Knee Replacement market was valued at 17253.29 Million USD in 2020 and will grow with a CAGR of 4.11% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East As......
  • 2021-2027 Global and Regional Stainless Steel Kirschner Wires Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global Stainless Steel Kirschner Wires market was valued at 23.11 Million USD in 2020 and will grow with a CAGR of 3.24% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, Eas......
  • 2021-2027 Global and Regional Biodegradable Stents Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global Biodegradable Stents market was valued at 724.75 Million USD in 2020 and will grow with a CAGR of 23.62% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, E......
  • 2021-2027 Global and Regional Liposomal Doxorubicin Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 160
    The global Liposomal Doxorubicin market was valued at 1032.23 Million USD in 2020 and will grow with a CAGR of 7.32% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, ......
  • 2021-2027 Global and Regional Sample Collection Swabs Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 151
    The global Sample Collection Swabs market was valued at 22.62 Million USD in 2020 and will grow with a CAGR of 7.27% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, ......
  • 2021-2027 Global and Regional Hemostat Powder Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 156
    The global Hemostat Powder market was valued at 31.65 Million USD in 2020 and will grow with a CAGR of 5.34% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, ......
  • 2021-2027 Global and Regional Bionic Devices Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 163
    The global Bionic Devices market was valued at 1198.57 Million USD in 2020 and will grow with a CAGR of 8.8% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, ......
  • 2021-2027 Global and Regional Medical Imaging Informatics Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 168
    The global Medical Imaging Informatics market was valued at 3582.76 Million USD in 2020 and will grow with a CAGR of 3.28% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East ......
  • 2021-2027 Global and Regional Bone Morphogenetic Protein (BMP) 2 Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 161
    The global Bone Morphogenetic Protein (BMP) 2 market was valued at 38.03 Million USD in 2020 and will grow with a CAGR of 2.19% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs